← Back to Clinical Trials
Recruiting NCT06585618

NCT06585618 A Multicenter Pediatric Deep Brain Stimulation Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06585618
Status Recruiting
Phase
Sponsor Boston Children's Hospital
Condition Dystonia
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2024-07-30
Primary Completion 2029-07-30

Eligibility & Interventions

Sex All sexes
Min Age 0 Years
Max Age 18 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2024-07-30 with a primary completion date of 2029-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack sufficient cases to power research studies adequately. This study aims to develop a multicenter pediatric DBS registry that allows multiple sites to share clinical pediatric DBS data. The primary goals are to enable large-scale, well-powered analyses of the safety and efficacy of DBS in the pediatric population and to further explore and refine DBS as a therapeutic option for children with dystonia and other hyperkinetic movement disorders. Given the current scarcity of evidence available to clinicians, this centralized multicenter repository of clinical data is critical for addressing key research questions and improving clinical practice for pediatric DBS.

Eligibility Criteria

Inclusion Criteria: * Female or male patients between ages of 0-18 years. * Having received or scheduled to receive DBS for any neurological movement disorder. * Parents or legal guardians are able to provide written consent for prospective enrollment.

Contact & Investigator

Central Contact

Darius Ebrahimi-Fakhari, MD, PhD

✉ movementdisorders@children.harvard.edu

📞 617-355-0097

Frequently Asked Questions

Who can join the NCT06585618 clinical trial?

This trial is open to participants of all sexes, aged 0 Years or older, up to 18 Years, studying Dystonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06585618 currently recruiting?

Yes, NCT06585618 is actively recruiting participants. Contact the research team at movementdisorders@children.harvard.edu for enrollment information.

Where is the NCT06585618 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT06585618 clinical trial?

NCT06585618 is sponsored by Boston Children's Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology